Penumbra, a global interventional therapies company that makes and markets medical devices, filed on Friday with the SEC to raise up to $115 million in an initial public offering.
The Alameda, CA-based company, which was founded in 2004 and booked $149 million in sales for the 12 months ended June 30, 2015, under the symbol PEN. J.P. Morgan, BofA Merrill Lynch, Wells Fargo Securities and Canaccord Genuity are the joint bookrunners on the deal. No pricing terms were disclosed.
